Signet Financial Management LLC grew its stake in Hologic, Inc. (NASDAQ:HOLX – Free Report) by 1.1% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 22,994 shares of the medical equipment provider’s stock after buying an additional 253 shares during the […]
Partnership Includes Education and Training to Increase Clinician Confidence in the Use of CEM, an Emerging Breast Imaging Modality Hologic Inc. (Nasdaq: HOLX) and Bayer today announced an interna…
Hologic needs catalysts such as sales growth, higher profits, or valuation factors to drive its stock price higher. Learn why I revise HOLX stock to hold.
Elo Mutual Pension Insurance Co lifted its stake in Hologic, Inc. (NASDAQ:HOLX – Free Report) by 2.3% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 19,750 shares of the medical equipment provider’s stock after buying an additional 449 shares during the period. […]
Is Hologic (HOLX) Modestly Overvalued? A Comprehensive Valuation Analysis
Hologic Inc., a leading developer and manufacturer of medical products, recently announced its financial results for the third quarter of 2023. The company experienced a slight decline in revenue, with a year-over-year decrease of 1.8% to $984.4 million. This decrease can be attributed to lower sales of COVID-19 assays compared to the previous year. However, […] The post Hologic Inc Announces Financial Results for Q3 2023 and Provides Fiscal Year Outlook appeared first on Best Stocks .
Hologic Inc (NASDAQ: HOLX ) posted Q3 adjusted EPS of $0.93, down from $0.95 a year ago and beating the consensus of $0.88 . Revenue of $984.4 million decreased 1.8% Y/Y (down 1.6% on constant currency), driven by lower sales of COVID-19 assays compared to the prior year period, as expected, exceeded the company''s prior guidance of $930-$980 million and the Full story available on Benzinga.com
Priority Support on Speed Dial: Minicarm.com - The Partner You Can Always Count On HAUPPAUGE, NY / ACCESSWIRE / August 1, 2023 / Orthoscan announced the End of Life (EOL) plan for its Orthoscan FD, FD-OR, Mobile DI (MDI), and FD Pulse Mini C-Arms. The following Mini C-Arms are scheduled to reach their EOL on the specified dates below. The EOL designation signifies that these machines have served their purpose diligently, yet due to various reasons, such as the discontinuation of component technology or the lack of ongoing support from raw material suppliers, their life cycle is coming to a close. Logo Product Model Serial Numbers EOL Date Orthoscan FD 1000-0004 5F0101 to 5F0638 7/14/2024 Orthoscan FD-OR 1000-0004 5H0101 to 5H0454 7/14/2024 Orthoscan Mobile DI 1000-0005 5G0101 to 5G0693 7/14/2024 Orthoscan FD Pulse 1000-0004-FD 5J0101 to 5J0753 7/14/2024 Despite the End of Life (EOL) status of Orthoscan FD, FD-OR, Mobile DI, and FD Pulse Mini C-Arms , Minicarm.com remains steadfast in its commitment to support these machines.
Hologic CEO Steve MacMillan joins ''Squawk on the Street'' to discuss MacMillan''s expectations for the company post-Covid, how the CEO is allocating capital, and more.
Hologic Inc. (HOLX) CEO Steve MacMillan said he doesn''t plan to go anywhere after he was appointed chairman of Illumina (ILMN) in June. "Let’s be really clear; I’m going to be at…